Koyfin Home > Directory > Health Care > Gilead Sciences Inc > Total Debt / EBITDA

Gilead Sciences Inc Total Debt / EBITDA Chart (GILD)

Gilead Sciences Inc annual/quarterly Total Debt / EBITDA from 2010 to 2020.
  • Gilead Sciences Inc Total Debt / EBITDA for the quarter ending September 09, 2020 was $2m a -33.51% decrease of -1m year over year
  • Gilead Sciences Inc Total Debt / EBITDA for the last 12 months ending September 09, 2020 was $5m a 17.55% increase of 1m year over year
  • Gilead Sciences Inc Annual Total Debt / EBITDA for 2019 was $4m a 31.29% increase of 1m from 2018
  • Gilead Sciences Inc Annual Total Debt / EBITDA for 2018 was $3m a 16.76% increase of 0m from 2017
  • Gilead Sciences Inc Annual Total Debt / EBITDA for 2017 was $2m a 37.03% increase of 1m from 2016
Other Ratios Metrics:
  • Gilead Sciences Inc Total Debt / Capital for the quarter ending December 12, 2018 was $59m a 1.63% increase of 1m year over year
  • Gilead Sciences Inc Other Liabilities for the quarter ending September 09, 2018 was $6,612m a -11.19% decrease of -740m year over year
  • Gilead Sciences Inc Total Debt / Equity for the quarter ending December 12, 2018 was $146m a 3.93% increase of 6m year over year
View Chart On Koyfin

Quarterly GILD Total Debt / EBITDA Data

09/2020$2m
06/2020$3m
03/2020$2m
12/2019$3m
09/2019$2m
06/2019$2m
03/2019$3m
12/2018$3m
09/2018$2m
06/2018$3m

Annual GILD Total Debt / EBITDA Data

2019$4m
2018$3m
2017$2m
2016$1m
2015$1m
2014$1m
2013$1m
2012$2m
2011$2m
2010$1m